Quick Order Cart

Cat. No. ARG31582

GSS Knockout NCI-H1975 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Lung

  • Disease:

    Carcinoma

CRISPR/Cas9-edited polyclonal knockout cell population targeting the glutathione synthetase (GSS) gene in the human non-small cell lung cancer cell line NCI-H1975. GSS catalyzes glutathione (GSH) biosynthesis, a critical antioxidant that supports GPX4-mediated lipid peroxide detoxification and protects against ferroptosis. The NCI-H1975 background harbors EGFR L858R and T790M mutations, modeling drug-resistant lung adenocarcinoma. GSS knockout depletes GSH, rendering cells vulnerable to oxidative stress and ferroptosis, and is useful for investigating redox vulnerabilities and chemoresistance. Typical applications include lipid peroxidation assays, ROS detection, and viability testing with ferroptosis inducers such as erastin and RSL3.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    NCI-H1975

    Sex of Donor

    Female

    Gene Name

    GSS

    Gene Identifier

    NCBI Gene ID 2937

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The GSS Knockout NCI-H1975 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population targeting the glutathione synthetase (GSS) gene in the human non-small cell lung cancer (NSCLC) cell line NCI-H1975. This product provides a heterogeneous pool of cells with GSS gene disruption, enabling loss-of-function studies without clonal selection. The polyclonal format maintains population diversity while abrogating GSS expression, suitable for redox biology and tumor vulnerability studies in a lung adenocarcinoma background.

The NCI-H1975 cell line originates from the pleural effusion of a nonsmoking female with lung adenocarcinoma and is a widely used NSCLC model. It harbors EGFR L858R and T790M mutations, conferring constitutive kinase activity and resistance to first-generation tyrosine kinase inhibitors, respectively. These genetic features make the cell line particularly relevant for studying signaling dependencies, metabolic adaptation, and drug resistance in EGFR-mutant lung cancer.

GSS encodes glutathione synthetase, catalyzing the final step of glutathione (GSH) synthesis by ligating gamma-glutamylcysteine and glycine. GSH is a critical antioxidant that serves as a cofactor for GPX4 to reduce lipid peroxides and prevent ferroptosis, and for glutathione S-transferases in detoxification. GSS is transcriptionally regulated by NFE2L2 (Nrf2) under oxidative stress, and functions downstream of GCL and upstream of glutathione reductase. The pathway integrates with SLC7A11-mediated cystine import, positioning GSS at a central node in ferroptosis defense and cellular redox homeostasis.

In NCI-H1975 cells, GSS knockout depletes GSH, impairing redox balance and sensitizing cells to oxidative stress and ferroptosis. EGFR-mutant NSCLC cells often rely on heightened antioxidant capacity to manage oncogenic stress, making the GSH system a therapeutically relevant vulnerability. This model enables dissection of redox-dependent cell death mechanisms and evaluation of ferroptosis-targeting strategies in a relevant lung adenocarcinoma background.

The polyclonal knockout cells are suitable for functional assays including GSH/GSSG ratio measurements, lipid peroxidation detection by C11-BODIPY, and ROS quantification by flow cytometry. Cell viability responses to ferroptosis inducers (erastin, RSL3) can be assessed in colony formation and xenograft models. Western blotting for GPX4 and SLC7A11 confirms pathway involvement. For further information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)